Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of fibrotic pericytes and their transcriptional regulation in pulmonary fibrosis.

Nature communications·2026
Same author

Chest Compressions as a Precipitant of Aortocaval Hematoma and Pseudoaneurysm in the Setting of Inferior Vena Cava (IVC) Filter Aortic Penetration: A Case Report.

Cureus·2026
Same author

Pulmonic Valve Insufficiency After Repair of Tetralogy of Fallot: A Case Report.

Cureus·2026
Same author

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review.

Annals of internal medicine·2026
Same author

FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma.

International journal of oncology·2026
Same author

Bilateral Congenital Stapes Footplate Fixation With Absence of the Stapedial Tendon.

The Permanente journal·2026

Related Experiment Video

Updated: Jan 16, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Nanoparticle-Based Delivery Systems for Synergistic Therapy in Lung Cancers.

Zicheng Deng1, Ali Al Siraj1,2, Isabella Lowry1,2

  • 1Phoenix Children's Research Institute, Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.

Bioengineering (Basel, Switzerland)
|September 27, 2025
PubMed
Summary

Nanoparticle delivery systems offer a novel approach to lung cancer treatment by co-delivering multiple agents. These advanced systems aim to enhance efficacy and overcome drug resistance in lung cancer patients.

Keywords:
drug deliverydrug resistancegene therapylung cancernanoparticlesynergistic therapy

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.4K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K

Related Experiment Videos

Last Updated: Jan 16, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.4K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • Conventional treatments face challenges like systemic toxicity, varying tumor sensitivity, and multidrug resistance.
  • Nanoparticle-based delivery systems present an innovative strategy to overcome these limitations.

Purpose of the Study:

  • To review nanoparticle-based delivery systems for lung cancer therapy.
  • To explore various nanocarrier platforms for co-delivery of therapeutic agents.
  • To highlight the potential of these systems in improving lung cancer treatment outcomes.

Main Methods:

  • Review of existing literature on nanoparticle-based drug and gene delivery for lung cancer.
  • Analysis of different nanocarrier platforms including liposomes, solid lipid nanoparticles, polymeric micelles, and inorganic nanoparticles.
  • Discussion of co-delivery strategies: drug-drug, gene-gene, and drug-gene.

Main Results:

  • Nanoparticle systems enable simultaneous transport of multiple agents (drugs, genes) for enhanced lung cancer therapy.
  • Various nanocarrier platforms are being developed for targeted lung cancer treatment.
  • Consideration of synergistic effects and physicochemical properties is crucial for effective co-delivery system design.

Conclusions:

  • Nanoparticle-based co-delivery systems offer a promising therapeutic strategy for lung cancer.
  • These systems can enhance treatment efficacy and overcome multidrug resistance.
  • Further development holds potential to significantly improve outcomes for lung cancer patients.